Estatísticas para Immunogenicity, effectiveness, and safety of inactivated virus (CoronaVac) vaccine in a two-dose primary protocol and BNT162b2 heterologous booster in Brazil (Immunita-001) : a one year period follow up phase 4 study.
Total de visitas
| views | |
|---|---|
| Immunogenicity, effectiveness, and safety of inactivated virus (CoronaVac) vaccine in a two-dose primary protocol and BNT162b2 heterologous booster in Brazil (Immunita-001) : a one year period follow up phase 4 study. | 0 |
Total visitas por mês
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
Visitas ao Arquivo
| views | |
|---|---|
| ARTIGO_ImmunogenicityEffectivenessSafety.pdf | 1 |